Provider
QP74-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Isturisa PA with QL
Program effective Date: Aug 12, 2020
Search Results
Displaying 2521 - 2530 of 3700 results
Provider
QP73-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Bempedoic Acid PA with QL
Program effective Date: Aug 12, 2020
Provider
QP81-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Risdiplam PA with QL
Program effective Date: Aug 26, 2020
Provider
QP79-20 Introducing the Blue Cross Blue Shield System’s New National High-Performance Network
Program effective Date: Aug 26, 2020
Provider
QP64R1-20 Medical Drug Update for New to Market Viltolarsen (Viltepso)
Program effective Date: Aug 26, 2020
Provider
P68-20 Radiology Cardiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Program effective Date: Sep 01, 2020
Provider
P64-20 Update to the Common Carrier and Special Transportation Services Addendums
Program effective Date: Sep 01, 2020
Provider
P66-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Program effective Date: Sep 01, 2020
Provider
QP83-20 Preventive Care Outreach Campaign for ACA Individual and Small Group (with Carenet Health)
Program effective Date: Aug 26, 2020
Provider
QP72-20 MHCP Pharmacy Benefit Update – Pharmacy Benefit Exclusion for Anjeso™, Fetroja®, Herzuma®, Ontruzant®, Potassium Phosphates, Scenesse® and Trazimera™
Program effective Date: Aug 12, 2020